BioMarin Files Vosoritide For Achondroplasia, But Investors Still Upset About Gene Therapy Setback

 
• By Jessica Merrill
  
Milestone - white wooden signpost with one arrow
BioMarin met one of two big milestones for the second half of the year • Source: Shutterstock

More from New Products

More from Scrip